From various sources, including Reuters and Canada sites:
Canada banned Pfizer Inc.'s arthritis drug Bextra this December of 2005 because of risks of heart attacks and strokes. Bextra sales in Canada had been suspended by Pfizer in April at the government's request.
"Following a review of safety information, Health Canada is informing the public that Bextra, an anti-inflammatory drug used to treat arthritis and pain, will not return to the market," the government said in a statement.
